> top > docs > PMC:1064895 > spans > 5681-6455 > annotations

PMC:1064895 / 5681-6455 JSONTXT

Annnotations TAB JSON ListView MergeView

2_test

Id Subject Object Predicate Lexical cue
15642134-3358796-4202023 204-206 3358796 denotes 17

biosemtest

Id Subject Object Predicate Lexical cue
T4844 647-652 UMLS/C0439234 denotes forme
T4843 626-631 UMLS/C0439234 denotes ange
T4842 607-612 UMLS/C0439234 denotes and 3
T4841 586-591 UMLS/C0439234 denotes (ran
T4840 288-293 UMLS/C0439234 denotes s). A
T4839 267-272 UMLS/C0439234 denotes ars (
T4838 354-359 UMLS/C0008972 denotes y. Co
T4837 190-201 UMLS/C0699792 denotes Association
T4836 354-359 UMLS/C0008976 denotes y. Co
T4835 519-523 UMLS/C0001792 denotes of
T4834 213-216 UMLS/C0001792 denotes age
T4833 564-572 UMLS/C0332298 denotes rols wer
T4832 449-457 UMLS/C0332298 denotes rols (3
T4831 531-539 UMLS/C1705908 denotes ents wit
T4830 391-399 UMLS/C1705908 denotes ents wit
T4829 224-232 UMLS/C1705908 denotes patients
T4828 38-46 UMLS/C1705908 denotes patients
T4826 694-702 UMLS/C0442711 denotes as appro
T4825 676-684 UMLS/C1301820 denotes and the
T4824 21-29 UMLS/C1301820 denotes obtained
T4823 694-702 UMLS/C2348563 denotes as appro
T4822 707-715 UMLS/C1549489 denotes y the Ca
T4821 514-518 UMLS/C0876919 denotes age
T4820 254-258 UMLS/C0876919 denotes ean
T4819 461-464 UMLS/C1281583 denotes and
T4818 411-414 UMLS/C1281583 denotes and
T4817 50-53 UMLS/C1281583 denotes men
T4816 752-757 UMLS/C0020156 denotes arch
T4815 707-715 UMLS/C0205540 denotes y the Ca
T4814 707-715 UMLS/C2346846 denotes y the Ca
T4813 461-464 UMLS/C0086418 denotes and
T4812 411-414 UMLS/C0086418 denotes and
T4811 50-53 UMLS/C0086418 denotes men
T4810 461-464 UMLS/C0018563 denotes and
T4809 411-414 UMLS/C0018563 denotes and
T4808 50-53 UMLS/C0018563 denotes men
T4807 354-359 UMLS/C2603343 denotes y. Co
T4806 564-572 UMLS/C0009932 denotes rols wer
T4805 449-457 UMLS/C0009932 denotes rols (3
T4804 80-89 UMLS/C1550543 denotes fulfilled
T4803 694-702 UMLS/C2349977 denotes as appro
T4802 354-359 UMLS/C2349977 denotes y. Co
T4801 461-464 UMLS/C0030736 denotes and
T4800 411-414 UMLS/C0030736 denotes and
T4799 50-53 UMLS/C0030736 denotes men
T4798 107-115 UMLS/C0243161 denotes criteria
T4797 317-324 UMLS/C1522314 denotes ped 48
T4796 531-539 UMLS/C0030705 denotes ents wit
T4795 391-399 UMLS/C0030705 denotes ents wit
T4794 224-232 UMLS/C0030705 denotes patients
T4793 38-46 UMLS/C0030705 denotes patients
T4791 354-359 UMLS/C1705923 denotes y. Co
T4790 490-508 UMLS/C0035435 denotes matic diseases. Th
T4789 179-189 UMLS/C0035435 denotes Rheumatism
T4788 132-139 UMLS/C0557806 denotes College
T4787 143-155 UMLS/C0035452 denotes Rheumatology
T4786 341-346 UMLS/C1705654 denotes y to
T4785 341-346 UMLS/C1550548 denotes y to
T4784 564-572 UMLS/C0243148 denotes rols wer
T4783 449-457 UMLS/C0243148 denotes rols (3
T4782 317-324 UMLS/C0450446 denotes ped 48
T4781 461-464 UMLS/C1690528 denotes and
T4780 411-414 UMLS/C1690528 denotes and
T4779 50-53 UMLS/C1690528 denotes men
T4778 190-201 UMLS/C0004083 denotes Association
T4777 531-539 UMLS/C1578479 denotes ents wit
T4776 391-399 UMLS/C1578479 denotes ents wit
T4775 224-232 UMLS/C1578479 denotes patients
T4774 38-46 UMLS/C1578479 denotes patients
T4772 170-178 UMLS/C0596070 denotes American
T4771 123-131 UMLS/C0596070 denotes American
T4770 531-539 UMLS/C1578483 denotes ents wit
T4769 391-399 UMLS/C1578483 denotes ents wit
T4768 224-232 UMLS/C1578483 denotes patients
T4767 38-46 UMLS/C1578483 denotes patients
T4765 647-652 UMLS/C1561543 denotes forme
T4764 626-631 UMLS/C1561543 denotes ange
T4763 607-612 UMLS/C1561543 denotes and 3
T4762 586-591 UMLS/C1561543 denotes (ran
T4761 288-293 UMLS/C1561543 denotes s). A
T4760 267-272 UMLS/C1561543 denotes ars (
T4759 531-539 UMLS/C1578480 denotes ents wit
T4758 391-399 UMLS/C1578480 denotes ents wit
T4757 224-232 UMLS/C1578480 denotes patients
T4756 38-46 UMLS/C1578480 denotes patients
T4754 531-539 UMLS/C1578481 denotes ents wit
T4753 391-399 UMLS/C1578481 denotes ents wit
T4752 224-232 UMLS/C1578481 denotes patients
T4751 38-46 UMLS/C1578481 denotes patients
T4749 531-539 UMLS/C1578486 denotes ents wit
T4748 391-399 UMLS/C1578486 denotes ents wit
T4747 224-232 UMLS/C1578486 denotes patients
T4746 38-46 UMLS/C1578486 denotes patients
T4744 707-715 UMLS/C1706842 denotes y the Ca
T4743 531-539 UMLS/C1578484 denotes ents wit
T4742 391-399 UMLS/C1578484 denotes ents wit
T4741 224-232 UMLS/C1578484 denotes patients
T4740 38-46 UMLS/C1578484 denotes patients
T4738 531-539 UMLS/C1578485 denotes ents wit
T4737 391-399 UMLS/C1578485 denotes ents wit
T4736 224-232 UMLS/C1578485 denotes patients
T4735 38-46 UMLS/C1578485 denotes patients
T4733 732-742 UMLS/C0041740 denotes of Korea
T4732 300-311 UMLS/C0013227 denotes cations wer
T4731 190-201 UMLS/C0596306 denotes Association
T4730 461-464 UMLS/C0949399 denotes and
T4729 411-414 UMLS/C0949399 denotes and
T4728 50-53 UMLS/C0949399 denotes men
T4727 531-539 UMLS/C1550655 denotes ents wit
T4726 391-399 UMLS/C1550655 denotes ents wit
T4725 224-232 UMLS/C1550655 denotes patients
T4724 38-46 UMLS/C1550655 denotes patients
T4722 190-201 UMLS/C0439849 denotes Association
T4721 655-671 UMLS/C0021430 denotes onsent was obtai
T4720 0-16 UMLS/C0021430 denotes Informed consent
T4719 746-751 UMLS/C0022771 denotes n Res
T4718 317-324 UMLS/C1947925 denotes ped 48
T4717 354-359 UMLS/C1880229 denotes y. Co
T4716 564-572 UMLS/C1547100 denotes rols wer
T4715 449-457 UMLS/C1547100 denotes rols (3
T4714 647-652 UMLS/C1561544 denotes forme
T4713 626-631 UMLS/C1561544 denotes ange
T4712 607-612 UMLS/C1561544 denotes and 3
T4711 586-591 UMLS/C1561544 denotes (ran
T4710 288-293 UMLS/C1561544 denotes s). A
T4709 267-272 UMLS/C1561544 denotes ars (
T4708 300-311 UMLS/C2598133 denotes cations wer
T4707 633-638 UMLS/C2348147 denotes –57 y
T4706 593-598 UMLS/C2348147 denotes 34–6
T4705 274-279 UMLS/C2348147 denotes nge 2
T4704 325-333 UMLS/C0439586 denotes ours bef
T4703 347-349 UMLS/C0319022 denotes he
T4702 300-311 UMLS/C0802604 denotes cations wer
T4701 694-702 UMLS/C1507394 denotes as appro
T4700 354-359 UMLS/C0557651 denotes y. Co
T4699 633-638 UMLS/C1514721 denotes –57 y
T4698 593-598 UMLS/C1514721 denotes 34–6
T4697 274-279 UMLS/C1514721 denotes nge 2
T4696 354-359 UMLS/C0947630 denotes y. Co
T4695 519-523 UMLS/C1114365 denotes of
T4694 213-216 UMLS/C1114365 denotes age
T4693 514-518 UMLS/C2347634 denotes age
T4692 254-258 UMLS/C2347634 denotes ean
T4691 262-265 UMLS/C0262878 denotes M)
T4690 694-702 UMLS/C1522729 denotes as appro
T4689 361-372 UMLS/C1707455 denotes arisons wer
T4688 564-572 UMLS/C1550141 denotes rols wer
T4687 449-457 UMLS/C1550141 denotes rols (3
T4686 341-346 UMLS/C1555714 denotes y to
T4685 514-518 UMLS/C1704970 denotes age
T4684 254-258 UMLS/C1704970 denotes ean
T4683 564-572 UMLS/C1882979 denotes rols wer
T4682 449-457 UMLS/C1882979 denotes rols (3
T4871 514-518 UMLS/C0444504 denotes age
T4870 254-258 UMLS/C0444504 denotes ean
T4869 262-265 UMLS/C0432222 denotes M)
T4868 514-518 UMLS/C2348143 denotes age
T4867 254-258 UMLS/C2348143 denotes ean
T4866 99-106 UMLS/C1527075 denotes revised
T4865 564-572 UMLS/C2587213 denotes rols wer
T4864 449-457 UMLS/C2587213 denotes rols (3
T4863 143-155 UMLS/C0334889 denotes Rheumatology
T4862 325-333 UMLS/C1442464 denotes ours bef
T4861 647-652 UMLS/C0439508 denotes forme
T4860 626-631 UMLS/C0439508 denotes ange
T4859 607-612 UMLS/C0439508 denotes and 3
T4858 586-591 UMLS/C0439508 denotes (ran
T4857 288-293 UMLS/C0439508 denotes s). A
T4856 267-272 UMLS/C0439508 denotes ars (
T4855 461-464 UMLS/C0338831 denotes and
T4854 411-414 UMLS/C0338831 denotes and
T4853 50-53 UMLS/C0338831 denotes men
T4852 676-684 UMLS/C1706701 denotes and the
T4851 21-29 UMLS/C1706701 denotes obtained
T4850 519-523 UMLS/C0001811 denotes of
T4849 213-216 UMLS/C0001811 denotes age
T4848 190-201 UMLS/C1704771 denotes Association
T4847 190-201 UMLS/C1704770 denotes Association
T4846 519-523 UMLS/C0001779 denotes of
T4845 213-216 UMLS/C0001779 denotes age

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T5034 748-756 NNP denotes Research
T5033 742-747 NNP denotes Human
T5032 736-741 NNP denotes Korea
T5031 733-735 IN denotes of
T5030 722-732 NNP denotes University
T5029 713-721 NNP denotes Catholic
T5028 709-712 DT denotes the
T5027 706-708 IN denotes by
T5026 697-705 VB denotes approved
T5025 693-696 VB denotes was
T5024 684-692 NN denotes protocol
T5023 680-683 DT denotes the
T5022 676-679 CC denotes and
T5021 674-675 -COMMA- denotes ,
T5020 666-674 VB denotes obtained
T5019 662-665 VB denotes was
T5018 654-661 NN denotes consent
T5017 645-653 VB denotes Informed
T5016 642-643 -RRB- denotes )
T5015 637-642 NN denotes years
T5014 631-636 CD denotes 24–57
T5013 625-630 NN denotes range
T5012 624-625 -LRB- denotes (
T5011 618-623 NN denotes years
T5010 616-617 CD denotes 6
T5009 614-615 CC denotes ±
T5008 611-613 CD denotes 30
T5007 607-610 CC denotes and
T5006 605-606 -RRB- denotes )
T5005 600-605 NN denotes years
T5004 594-599 CD denotes 34–68
T5003 588-593 NN denotes range
T5002 587-588 -LRB- denotes (
T5001 581-586 NN denotes years
T5000 579-580 CD denotes 8
T4999 577-578 CC denotes ±
T4998 574-576 CD denotes 50
T4997 569-573 VB denotes were
T4996 560-568 NN denotes controls
T4995 552-559 JJ denotes healthy
T4994 548-551 DT denotes the
T4993 544-547 CC denotes and
T4992 541-543 NN denotes OA
T4991 536-540 IN denotes with
T4990 527-535 NN denotes patients
T4989 523-526 DT denotes the
T4988 520-522 IN denotes of
T4987 515-519 NN denotes ages
T4986 510-514 JJ denotes mean
T4985 506-509 DT denotes The
T4984 496-504 NN denotes diseases
T4983 486-495 JJ denotes rheumatic
T4982 483-485 DT denotes no
T4981 479-482 VB denotes had
T4980 475-478 WP denotes who
T4979 473-474 -RRB- denotes )
T4978 468-473 NN denotes women
T4977 465-467 CD denotes 11
T4976 461-464 CC denotes and
T4975 457-460 NN denotes men
T4974 455-456 CD denotes 3
T4973 454-455 -LRB- denotes (
T4972 445-453 NN denotes controls
T4971 437-444 JJ denotes healthy
T4970 434-436 CD denotes 14
T4969 429-433 IN denotes with
T4968 425-428 CC denotes and
T4967 423-424 -RRB- denotes )
T4966 418-423 NN denotes women
T4965 415-417 CD denotes 11
T4964 411-414 CC denotes and
T4963 407-410 NN denotes men
T4962 405-406 CD denotes 3
T4961 404-405 -LRB- denotes (
T4960 401-403 NN denotes OA
T4959 396-400 IN denotes with
T4958 387-395 NN denotes patients
T4957 384-386 CD denotes 14
T4956 379-383 IN denotes with
T4955 374-378 VB denotes made
T4954 369-373 VB denotes were
T4953 357-368 NN denotes Comparisons
T4952 350-355 NN denotes study
T4951 346-349 DT denotes the
T4950 343-345 TO denotes to
T4949 337-342 NN denotes entry
T4948 330-336 IN denotes before
T4947 324-329 NN denotes hours
T4946 321-323 CD denotes 48
T4945 313-320 VB denotes stopped
T4944 308-312 VB denotes were
T4943 296-307 NN denotes medications
T4942 292-295 DT denotes All
T4941 289-290 -RRB- denotes )
T4940 284-289 NN denotes years
T4939 278-283 CD denotes 23–71
T4938 272-277 NN denotes range
T4937 271-272 -LRB- denotes (
T4936 265-270 NN denotes years
T4935 263-264 -RRB- denotes )
T4934 260-263 NN denotes SEM
T4933 258-259 CC denotes ±
T4932 253-257 NN denotes mean
T4931 252-253 -LRB- denotes (
T4930 250-251 CD denotes 8
T4929 248-249 SYM denotes ±
T4928 245-247 CD denotes 50
T4927 241-244 VB denotes was
T4926 238-240 NN denotes RA
T4925 233-237 IN denotes with
T4924 224-232 NN denotes patients
T4923 220-223 DT denotes the
T4922 217-219 IN denotes of
T4921 213-216 NN denotes age
T4920 209-212 DT denotes The
T4919 206-207 -RRB- denotes ]
T4918 204-206 CD denotes 17
T4917 203-204 -LRB- denotes [
T4916 201-202 -RRB- denotes )
T4915 190-201 NNP denotes Association
T4914 179-189 NNP denotes Rheumatism
T4913 170-178 NNP denotes American
T4912 166-169 DT denotes the
T4911 157-165 RB denotes formerly
T4910 156-157 -LRB- denotes (
T4909 143-155 NNP denotes Rheumatology
T4908 140-142 IN denotes of
T4907 132-139 NNP denotes College
T4906 123-131 NNP denotes American
T4905 119-122 DT denotes the
T4904 116-118 IN denotes of
T4903 107-115 NN denotes criteria
T4902 99-106 VB denotes revised
T4901 94-98 CD denotes 1987
T4900 90-93 DT denotes the
T4899 80-89 VB denotes fulfilled
T4898 76-79 WP denotes who
T4897 73-75 NN denotes RA
T4896 68-72 IN denotes with
T4895 66-67 -RRB- denotes )
T4894 61-66 NN denotes women
T4893 58-60 CD denotes 19
T4892 54-57 CC denotes and
T4891 50-53 NN denotes men
T4890 48-49 CD denotes 5
T4889 47-48 -LRB- denotes (
T4888 38-46 NN denotes patients
T4887 35-37 CD denotes 24
T4886 30-34 IN denotes from
T4885 21-29 VB denotes obtained
T4884 17-20 VB denotes was
T4883 9-16 NN denotes consent
T4882 0-8 VB denotes Informed
T5036 764-773 NNP denotes Committee
T5035 757-763 NNP denotes Ethics
R2483 T4883 T4882 arg2Of consent,Informed
R2484 T4883 T4884 arg1Of consent,was
R2485 T4883 T4885 arg2Of consent,obtained
R2486 T4885 T4884 arg2Of obtained,was
R2487 T4885 T4886 arg1Of obtained,from
R2488 T4888 T4886 arg2Of patients,from
R2489 T4888 T4887 arg1Of patients,24
R2490 T4888 T4889 arg1Of patients,(
R2491 T4888 T4896 arg1Of patients,with
R2492 T4891 T4890 arg1Of men,5
R2493 T4891 T4892 arg1Of men,and
R2494 T4892 T4889 arg2Of and,(
R2495 T4894 T4892 arg2Of women,and
R2496 T4894 T4893 arg1Of women,19
R2497 T4895 T4889 arg3Of ),(
R2498 T4897 T4896 arg2Of RA,with
R2499 T4897 T4898 arg1Of RA,who
R2500 T4897 T4899 arg1Of RA,fulfilled
R2501 T4899 T4917 arg1Of fulfilled,[
R2502 T4903 T4899 arg2Of criteria,fulfilled
R2503 T4903 T4900 arg1Of criteria,the
R2504 T4903 T4901 arg1Of criteria,1987
R2505 T4903 T4902 arg2Of criteria,revised
R2506 T4903 T4904 arg1Of criteria,of
R2507 T4903 T4910 arg1Of criteria,(
R2508 T4907 T4904 arg2Of College,of
R2509 T4907 T4905 arg1Of College,the
R2510 T4907 T4906 arg1Of College,American
R2511 T4907 T4908 arg1Of College,of
R2512 T4909 T4908 arg2Of Rheumatology,of
R2513 T4915 T4910 arg2Of Association,(
R2514 T4915 T4911 arg1Of Association,formerly
R2515 T4915 T4912 arg1Of Association,the
R2516 T4915 T4913 arg1Of Association,American
R2517 T4915 T4914 arg1Of Association,Rheumatism
R2518 T4916 T4910 arg3Of ),(
R2519 T4918 T4917 arg2Of 17,[
R2520 T4919 T4917 arg3Of ],[
R2521 T4921 T4920 arg1Of age,The
R2522 T4921 T4922 arg1Of age,of
R2523 T4921 T4927 arg1Of age,was
R2524 T4924 T4922 arg2Of patients,of
R2525 T4924 T4923 arg1Of patients,the
R2526 T4924 T4925 arg1Of patients,with
R2527 T4926 T4925 arg2Of RA,with
R2528 T4932 T4933 arg1Of mean,±
R2529 T4933 T4931 arg2Of ±,(
R2530 T4934 T4933 arg2Of SEM,±
R2531 T4935 T4931 arg3Of ),(
R2532 T4936 T4927 arg2Of years,was
R2533 T4936 T4928 arg1Of years,50
R2534 T4936 T4929 arg1Of years,±
R2535 T4936 T4930 arg1Of years,8
R2536 T4936 T4931 arg1Of years,(
R2537 T4936 T4937 arg1Of years,(
R2538 T4940 T4937 arg2Of years,(
R2539 T4940 T4938 arg1Of years,range
R2540 T4940 T4939 arg1Of years,23–71
R2541 T4941 T4937 arg3Of ),(
R2542 T4943 T4942 arg1Of medications,All
R2543 T4943 T4944 arg1Of medications,were
R2544 T4943 T4945 arg2Of medications,stopped
R2545 T4945 T4944 arg2Of stopped,were
R2546 T4945 T4948 arg1Of stopped,before
R2547 T4947 T4946 arg1Of hours,48
R2548 T4948 T4947 arg1Of before,hours
R2549 T4949 T4948 arg2Of entry,before
R2550 T4949 T4950 arg1Of entry,to
R2551 T4952 T4950 arg2Of study,to
R2552 T4952 T4951 arg1Of study,the
R2553 T4953 T4954 arg1Of Comparisons,were
R2554 T4953 T4955 arg2Of Comparisons,made
R2555 T4955 T4954 arg2Of made,were
R2556 T4955 T4956 arg1Of made,with
R2557 T4955 T4969 arg1Of made,with
R2558 T4956 T4968 arg1Of with,and
R2559 T4958 T4956 arg2Of patients,with
R2560 T4958 T4957 arg1Of patients,14
R2561 T4958 T4959 arg1Of patients,with
R2562 T4958 T4961 arg1Of patients,(
R2563 T4960 T4959 arg2Of OA,with
R2564 T4963 T4962 arg1Of men,3
R2565 T4963 T4964 arg1Of men,and
R2566 T4964 T4961 arg2Of and,(
R2567 T4966 T4964 arg2Of women,and
R2568 T4966 T4965 arg1Of women,11
R2569 T4967 T4961 arg3Of ),(
R2570 T4969 T4968 arg2Of with,and
R2571 T4972 T4969 arg2Of controls,with
R2572 T4972 T4970 arg1Of controls,14
R2573 T4972 T4971 arg1Of controls,healthy
R2574 T4972 T4973 arg1Of controls,(
R2575 T4972 T4980 arg1Of controls,who
R2576 T4972 T4981 arg1Of controls,had
R2577 T4975 T4974 arg1Of men,3
R2578 T4975 T4976 arg1Of men,and
R2579 T4976 T4973 arg2Of and,(
R2580 T4978 T4976 arg2Of women,and
R2581 T4978 T4977 arg1Of women,11
R2582 T4979 T4973 arg3Of ),(
R2583 T4984 T4981 arg2Of diseases,had
R2584 T4984 T4982 arg1Of diseases,no
R2585 T4984 T4983 arg1Of diseases,rheumatic
R2586 T4987 T4985 arg1Of ages,The
R2587 T4987 T4986 arg1Of ages,mean
R2588 T4987 T4988 arg1Of ages,of
R2589 T4987 T4997 arg1Of ages,were
R2590 T4990 T4989 arg1Of patients,the
R2591 T4990 T4991 arg1Of patients,with
R2592 T4990 T4993 arg1Of patients,and
R2593 T4992 T4991 arg2Of OA,with
R2594 T4993 T4988 arg2Of and,of
R2595 T4996 T4993 arg2Of controls,and
R2596 T4996 T4994 arg1Of controls,the
R2597 T4996 T4995 arg1Of controls,healthy
R2598 T4998 T4999 arg1Of 50,±
R2599 T5000 T4999 arg2Of 8,±
R2600 T5001 T4998 arg1Of years,50
R2601 T5001 T5000 arg1Of years,8
R2602 T5001 T5002 arg1Of years,(
R2603 T5001 T5007 arg1Of years,and
R2604 T5005 T5002 arg2Of years,(
R2605 T5005 T5003 arg1Of years,range
R2606 T5005 T5004 arg1Of years,34–68
R2607 T5006 T5002 arg3Of ),(
R2608 T5007 T4997 arg2Of and,were
R2609 T5008 T5009 arg1Of 30,±
R2610 T5010 T5009 arg2Of 6,±
R2611 T5011 T5007 arg2Of years,and
R2612 T5011 T5008 arg1Of years,30
R2613 T5011 T5010 arg1Of years,6
R2614 T5011 T5012 arg1Of years,(
R2615 T5015 T5012 arg2Of years,(
R2616 T5015 T5013 arg1Of years,range
R2617 T5015 T5014 arg1Of years,24–57
R2618 T5016 T5012 arg3Of ),(
R2619 T5018 T5017 arg2Of consent,Informed
R2620 T5018 T5019 arg1Of consent,was
R2621 T5018 T5020 arg2Of consent,obtained
R2622 T5020 T5019 arg2Of obtained,was
R2623 T5020 T5022 arg1Of obtained,and
R2624 T5022 T5021 arg1Of and,","
R2625 T5024 T5023 arg1Of protocol,the
R2626 T5024 T5025 arg1Of protocol,was
R2627 T5024 T5026 arg2Of protocol,approved
R2628 T5026 T5022 arg2Of approved,and
R2629 T5026 T5025 arg2Of approved,was
R2630 T5030 T5026 arg1Of University,approved
R2631 T5030 T5027 arg2Of University,by
R2632 T5030 T5028 arg1Of University,the
R2633 T5030 T5029 arg1Of University,Catholic
R2634 T5030 T5031 arg1Of University,of
R2635 T5036 T5031 arg2Of Committee,of
R2636 T5036 T5032 arg1Of Committee,Korea
R2637 T5036 T5033 arg1Of Committee,Human
R2638 T5036 T5034 arg1Of Committee,Research
R2639 T5036 T5035 arg1Of Committee,Ethics

GO-BP

Id Subject Object Predicate Lexical cue
T4880 515-519 http://purl.obolibrary.org/obo/GO_0007568 denotes ages
T4879 213-216 http://purl.obolibrary.org/obo/GO_0007568 denotes age

sentences

Id Subject Object Predicate Lexical cue
T4878 645-774 Sentence denotes Informed consent was obtained, and the protocol was approved by the Catholic University of Korea Human Research Ethics Committee.
T4877 506-644 Sentence denotes The mean ages of the patients with OA and the healthy controls were 50 ± 8 years (range 34–68 years) and 30 ± 6 years (range 24–57 years).
T4876 357-505 Sentence denotes Comparisons were made with 14 patients with OA (3 men and 11 women) and with 14 healthy controls (3 men and 11 women) who had no rheumatic diseases.
T4875 292-356 Sentence denotes All medications were stopped 48 hours before entry to the study.
T4874 209-291 Sentence denotes The age of the patients with RA was 50 ± 8 (mean ± SEM) years (range 23–71 years).
T4873 0-208 Sentence denotes Informed consent was obtained from 24 patients (5 men and 19 women) with RA who fulfilled the 1987 revised criteria of the American College of Rheumatology (formerly the American Rheumatism Association) [17].
T38 0-208 Sentence denotes Informed consent was obtained from 24 patients (5 men and 19 women) with RA who fulfilled the 1987 revised criteria of the American College of Rheumatology (formerly the American Rheumatism Association) [17].
T39 209-291 Sentence denotes The age of the patients with RA was 50 ± 8 (mean ± SEM) years (range 23–71 years).
T40 292-356 Sentence denotes All medications were stopped 48 hours before entry to the study.
T41 357-505 Sentence denotes Comparisons were made with 14 patients with OA (3 men and 11 women) and with 14 healthy controls (3 men and 11 women) who had no rheumatic diseases.
T42 506-644 Sentence denotes The mean ages of the patients with OA and the healthy controls were 50 ± 8 years (range 34–68 years) and 30 ± 6 years (range 24–57 years).
T43 645-774 Sentence denotes Informed consent was obtained, and the protocol was approved by the Catholic University of Korea Human Research Ethics Committee.

ICD10

Id Subject Object Predicate Lexical cue
T5037 179-189 http://purl.bioontology.org/ontology/ICD10/M79.0 denotes Rheumatism

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T5208 541-543 Entity denotes OA
T5207 80-155 Entity denotes fulfilled the 1987 revised criteria of the American College of Rheumatology
T5206 73-75 Protein denotes RA
T5205 401-424 Entity denotes OA (3 men and 11 women)
T5204 292-307 Entity denotes All medications
T5203 238-240 Protein denotes RA

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T5202 773-774 . denotes .
T5201 764-773 NNP denotes Committee
T5200 757-763 NNP denotes Ethics
T5199 748-756 NNP denotes Research
T5198 742-747 NNP denotes Human
T5197 736-741 NNP denotes Korea
T5196 733-735 IN denotes of
T5195 722-732 NNP denotes University
T5194 713-721 NNP denotes Catholic
T5193 709-712 DT denotes the
T5192 706-708 IN denotes by
T5191 697-705 VBN denotes approved
T5190 693-696 VBD denotes was
T5189 684-692 NN denotes protocol
T5188 680-683 DT denotes the
T5187 676-679 CC denotes and
T5186 674-675 , denotes ,
T5185 666-674 VBN denotes obtained
T5184 662-665 VBD denotes was
T5183 654-661 NN denotes consent
T5182 645-653 VBN denotes Informed
T5181 643-644 . denotes .
T5180 642-643 -RRB- denotes )
T5179 637-642 NNS denotes years
T5178 634-636 CD denotes 57
T5177 631-633 CD denotes 24
T5176 625-630 NN denotes range
T5175 624-625 -LRB- denotes (
T5174 618-623 NNS denotes years
T5173 616-617 CD denotes 6
T5172 614-615 NN denotes ±
T5171 611-613 CD denotes 30
T5170 607-610 CC denotes and
T5169 605-606 -RRB- denotes )
T5168 600-605 NNS denotes years
T5167 597-599 CD denotes 68
T5166 594-596 CD denotes 34
T5165 588-593 NN denotes range
T5164 587-588 -LRB- denotes (
T5163 581-586 NNS denotes years
T5162 579-580 CD denotes 8
T5161 577-578 NN denotes ±
T5160 574-576 CD denotes 50
T5159 569-573 VBD denotes were
T5158 560-568 NNS denotes controls
T5157 552-559 JJ denotes healthy
T5156 548-551 DT denotes the
T5155 544-547 CC denotes and
T5154 541-543 NNP denotes OA
T5153 536-540 IN denotes with
T5152 527-535 NNS denotes patients
T5151 523-526 DT denotes the
T5150 520-522 IN denotes of
T5149 515-519 NNS denotes ages
T5148 510-514 JJ denotes mean
T5147 506-509 DT denotes The
T5146 504-505 . denotes .
T5145 496-504 NNS denotes diseases
T5144 486-495 JJ denotes rheumatic
T5143 483-485 DT denotes no
T5142 479-482 VBD denotes had
T5141 475-478 WP denotes who
T5140 473-474 -RRB- denotes )
T5139 468-473 NNS denotes women
T5138 465-467 CD denotes 11
T5137 461-464 CC denotes and
T5136 457-460 NNS denotes men
T5135 455-456 CD denotes 3
T5134 454-455 -LRB- denotes (
T5133 445-453 NNS denotes controls
T5132 437-444 JJ denotes healthy
T5131 434-436 CD denotes 14
T5130 429-433 IN denotes with
T5129 425-428 CC denotes and
T5128 423-424 -RRB- denotes )
T5127 418-423 NNS denotes women
T5126 415-417 CD denotes 11
T5125 411-414 CC denotes and
T5123 405-406 CD denotes 3
T5122 404-405 -LRB- denotes (
T5121 401-403 NNP denotes OA
T5120 396-400 IN denotes with
T5119 387-395 NNS denotes patients
T5118 384-386 CD denotes 14
T5117 379-383 IN denotes with
T5116 374-378 VBN denotes made
T5115 369-373 VBD denotes were
T5114 357-368 NNS denotes Comparisons
T5113 355-356 . denotes .
T5112 350-355 NN denotes study
T5111 346-349 DT denotes the
T5110 343-345 TO denotes to
T5109 337-342 NN denotes entry
T5108 330-336 IN denotes before
T5107 324-329 NNS denotes hours
T5106 321-323 CD denotes 48
T5105 313-320 VBN denotes stopped
T5104 308-312 VBD denotes were
T5103 296-307 NNS denotes medications
T5102 292-295 DT denotes All
T5101 290-291 . denotes .
T5100 289-290 -RRB- denotes )
T5099 284-289 NNS denotes years
T5098 281-283 CD denotes 71
T5097 278-280 CD denotes 23
T5096 272-277 NN denotes range
T5095 271-272 -LRB- denotes (
T5094 265-270 NNS denotes years
T5093 263-264 -RRB- denotes )
T5092 260-263 NNP denotes SEM
T5091 258-259 NN denotes ±
T5090 253-257 JJ denotes mean
T5089 252-253 -LRB- denotes (
T5088 250-251 CD denotes 8
T5087 248-249 NN denotes ±
T5086 245-247 CD denotes 50
T5085 241-244 VBD denotes was
T5084 238-240 NNP denotes RA
T5083 233-237 IN denotes with
T5082 224-232 NNS denotes patients
T5081 220-223 DT denotes the
T5080 217-219 IN denotes of
T5079 213-216 NN denotes age
T5078 209-212 DT denotes The
T5077 207-208 . denotes .
T5076 206-207 NNP denotes ]
T5075 204-206 CD denotes 17
T5074 203-204 NNP denotes [
T5073 201-202 -RRB- denotes )
T5072 190-201 NNP denotes Association
T5071 179-189 NNP denotes Rheumatism
T5070 170-178 JJ denotes American
T5069 166-169 DT denotes the
T5068 157-165 RB denotes formerly
T5067 156-157 -LRB- denotes (
T5066 143-155 NNP denotes Rheumatology
T5065 140-142 IN denotes of
T5064 132-139 NNP denotes College
T5063 123-131 JJ denotes American
T5062 119-122 DT denotes the
T5061 116-118 IN denotes of
T5060 107-115 NNS denotes criteria
T5059 99-106 VBN denotes revised
T5058 94-98 CD denotes 1987
T5057 90-93 DT denotes the
T5056 80-89 VBD denotes fulfilled
T5055 76-79 WP denotes who
T5054 73-75 NNP denotes RA
T5053 68-72 IN denotes with
T5052 66-67 -RRB- denotes )
T5051 61-66 NNS denotes women
T5050 58-60 CD denotes 19
T5049 54-57 CC denotes and
T5048 50-53 NNS denotes men
T5047 48-49 CD denotes 5
T5046 47-48 -LRB- denotes (
T5045 38-46 NNS denotes patients
T5044 35-37 CD denotes 24
T5043 30-34 IN denotes from
T5042 21-29 VBN denotes obtained
T5041 17-20 VBD denotes was
T5040 9-16 NN denotes consent
T5039 0-8 VBN denotes Informed
T5124 407-410 NNS denotes men
R2641 T5039 T5040 amod Informed,consent
R2642 T5040 T5042 nsubjpass consent,obtained
R2643 T5041 T5042 auxpass was,obtained
R2644 T5042 T5042 ROOT obtained,obtained
R2645 T5043 T5042 prep from,obtained
R2646 T5044 T5045 nummod 24,patients
R2647 T5045 T5043 pobj patients,from
R2648 T5046 T5045 punct (,patients
R2649 T5047 T5048 nummod 5,men
R2650 T5048 T5045 appos men,patients
R2651 T5049 T5048 cc and,men
R2652 T5050 T5051 nummod 19,women
R2653 T5051 T5048 conj women,men
R2654 T5052 T5045 punct ),patients
R2655 T5053 T5042 prep with,obtained
R2656 T5054 T5053 pobj RA,with
R2657 T5055 T5056 nsubj who,fulfilled
R2658 T5056 T5042 conj fulfilled,obtained
R2659 T5057 T5060 det the,criteria
R2660 T5058 T5060 nummod 1987,criteria
R2661 T5059 T5060 amod revised,criteria
R2662 T5060 T5056 dobj criteria,fulfilled
R2663 T5061 T5060 prep of,criteria
R2664 T5062 T5064 det the,College
R2665 T5063 T5064 compound American,College
R2666 T5064 T5061 pobj College,of
R2667 T5065 T5064 prep of,College
R2668 T5066 T5065 pobj Rheumatology,of
R2669 T5067 T5064 punct (,College
R2670 T5068 T5072 advmod formerly,Association
R2671 T5069 T5072 det the,Association
R2672 T5070 T5072 compound American,Association
R2673 T5071 T5072 compound Rheumatism,Association
R2674 T5072 T5064 appos Association,College
R2675 T5073 T5064 punct ),College
R2676 T5074 T5076 nmod [,]
R2677 T5075 T5076 nummod 17,]
R2678 T5076 T5060 appos ],criteria
R2679 T5077 T5042 punct .,obtained
R2680 T5078 T5079 det The,age
R2681 T5079 T5085 nsubj age,was
R2682 T5080 T5079 prep of,age
R2683 T5081 T5082 det the,patients
R2684 T5082 T5080 pobj patients,of
R2685 T5083 T5082 prep with,patients
R2686 T5084 T5083 pobj RA,with
R2687 T5085 T5085 ROOT was,was
R2688 T5086 T5087 nummod 50,±
R2689 T5087 T5085 attr ±,was
R2690 T5088 T5087 nummod 8,±
R2691 T5089 T5092 punct (,SEM
R2692 T5090 T5092 amod mean,SEM
R2693 T5091 T5092 compound ±,SEM
R2694 T5092 T5087 appos SEM,±
R2695 T5093 T5092 punct ),SEM
R2696 T5094 T5087 appos years,±
R2697 T5095 T5096 punct (,range
R2698 T5096 T5087 appos range,±
R2699 T5097 T5096 nummod 23,range
R2700 T5098 T5099 nummod 71,years
R2701 T5099 T5096 appos years,range
R2702 T5100 T5096 punct ),range
R2703 T5101 T5087 punct .,±
R2704 T5102 T5103 det All,medications
R2705 T5103 T5105 nsubjpass medications,stopped
R2706 T5104 T5105 auxpass were,stopped
R2707 T5105 T5105 ROOT stopped,stopped
R2708 T5106 T5107 nummod 48,hours
R2709 T5107 T5108 npadvmod hours,before
R2710 T5108 T5105 prep before,stopped
R2711 T5109 T5108 pobj entry,before
R2712 T5110 T5109 prep to,entry
R2713 T5111 T5112 det the,study
R2714 T5112 T5110 pobj study,to
R2715 T5113 T5105 punct .,stopped
R2716 T5114 T5116 nsubjpass Comparisons,made
R2717 T5115 T5116 auxpass were,made
R2718 T5116 T5116 ROOT made,made
R2719 T5117 T5116 prep with,made
R2720 T5118 T5119 nummod 14,patients
R2721 T5119 T5117 pobj patients,with
R2722 T5120 T5119 prep with,patients
R2723 T5121 T5120 pobj OA,with
R2724 T5122 T5121 punct (,OA
R2725 T5123 T5124 nummod 3,men
R2726 T5124 T5121 appos men,OA
R2727 T5125 T5124 cc and,men
R2728 T5126 T5127 nummod 11,women
R2729 T5127 T5124 conj women,men
R2730 T5128 T5121 punct ),OA
R2731 T5129 T5120 cc and,with
R2732 T5130 T5120 conj with,with
R2733 T5131 T5133 nummod 14,controls
R2734 T5132 T5133 amod healthy,controls
R2735 T5133 T5130 pobj controls,with
R2736 T5134 T5133 punct (,controls
R2737 T5135 T5136 nummod 3,men
R2738 T5136 T5133 appos men,controls
R2739 T5137 T5136 cc and,men
R2740 T5138 T5139 nummod 11,women
R2741 T5139 T5136 conj women,men
R2742 T5140 T5133 punct ),controls
R2743 T5141 T5142 nsubj who,had
R2744 T5142 T5133 relcl had,controls
R2745 T5143 T5145 det no,diseases
R2746 T5144 T5145 amod rheumatic,diseases
R2747 T5145 T5142 dobj diseases,had
R2748 T5146 T5116 punct .,made
R2749 T5147 T5149 det The,ages
R2750 T5148 T5149 amod mean,ages
R2751 T5149 T5159 nsubj ages,were
R2752 T5150 T5149 prep of,ages
R2753 T5151 T5152 det the,patients
R2754 T5152 T5150 pobj patients,of
R2755 T5153 T5152 prep with,patients
R2756 T5154 T5153 pobj OA,with
R2757 T5155 T5154 cc and,OA
R2758 T5156 T5158 det the,controls
R2759 T5157 T5158 amod healthy,controls
R2760 T5158 T5154 conj controls,OA
R2761 T5159 T5159 ROOT were,were
R2762 T5160 T5161 nummod 50,±
R2763 T5161 T5159 attr ±,were
R2764 T5162 T5163 nummod 8,years
R2765 T5163 T5161 appos years,±
R2766 T5164 T5165 punct (,range
R2767 T5165 T5163 parataxis range,years
R2768 T5166 T5165 nummod 34,range
R2769 T5167 T5168 nummod 68,years
R2770 T5168 T5165 appos years,range
R2771 T5169 T5165 punct ),range
R2772 T5170 T5163 cc and,years
R2773 T5171 T5172 nummod 30,±
R2774 T5172 T5163 conj ±,years
R2775 T5173 T5174 nummod 6,years
R2776 T5174 T5172 appos years,±
R2777 T5175 T5176 punct (,range
R2778 T5176 T5174 parataxis range,years
R2779 T5177 T5176 nummod 24,range
R2780 T5178 T5179 nummod 57,years
R2781 T5179 T5176 appos years,range
R2782 T5180 T5176 punct ),range
R2783 T5181 T5159 punct .,were
R2784 T5182 T5183 amod Informed,consent
R2785 T5183 T5185 nsubjpass consent,obtained
R2786 T5184 T5185 auxpass was,obtained
R2787 T5185 T5185 ROOT obtained,obtained
R2788 T5186 T5185 punct ",",obtained
R2789 T5187 T5185 cc and,obtained
R2790 T5188 T5189 det the,protocol
R2791 T5189 T5191 nsubjpass protocol,approved
R2792 T5190 T5191 auxpass was,approved
R2793 T5191 T5185 conj approved,obtained
R2794 T5192 T5191 agent by,approved
R2795 T5193 T5195 det the,University
R2796 T5194 T5195 compound Catholic,University
R2797 T5195 T5201 nmod University,Committee
R2798 T5196 T5195 prep of,University
R2799 T5197 T5196 pobj Korea,of
R2800 T5198 T5200 compound Human,Ethics
R2801 T5199 T5200 compound Research,Ethics
R2802 T5200 T5201 compound Ethics,Committee
R2803 T5201 T5192 pobj Committee,by
R2804 T5202 T5191 punct .,approved